Purpose: The mechanisms for drug interactions with smoking and clinically significant pharmacokinetic and pharmacodynamic drug interactions with smoking are reviewed. Summary: Polycyclic aromatic ...

The half-life of CYP1A2 activity after smoking cessation was 38.6 hours. The authors recommended a 10% daily-dose reduction for drugs that are CYP1A2 substrates until the fourth day after smoking ...